Thabor Therapeutics
About:
Thabor Therapeutics develops innovative treatments for mucosal inflammatory diseases.
Website: http://www.thabor-tx.com
Top Investors: Bpifrance, AdBio partners
Description:
Thabor Therapeutics develops innovative treatments for mucosal inflammatory diseases. They concentrated on inhibiting a new target to treat human mucosal inflammatory disorders. They also enable healthcare providers to cure their patients.
Total Funding Amount:
2M EUR
Headquarters Location:
Paris, Ile-de-France, France
Founded Date:
2021-01-01
Founders:
Marina Guillet
Number of Employees:
1-10
Last Funding Date:
2022-07-06
IPO Status:
Private
Industries:
© 2025 bioDAO.ai